4D Molecular Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

4D Molecular Therapeutics

09/08/2024 05:57

* 4D Molecular Therapeutics Inc  FDMT.OQ  reported a
quarterly
adjusted loss of 63 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -77 cents.  The mean expectation of ten analysts
for the quarter was for a loss of 70 cents per share. Wall
Street expected results to range from -81 cents to -61 cents per
share.
    * Revenue fell 97.9% to $5.00 thousand from a year ago;
analysts
expected $1.31 million. 
    * 4D Molecular Therapeutics Inc's reported EPS for the
quarter was
a loss of 63 cents​.
    * The company reported a quarterly loss of $34.95 million.
    * 4D Molecular Therapeutics Inc shares had fallen by 29.9%
this
quarter and lost 27.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for 4D Molecular
Therapeutics Inc is $43.00 
This summary was machine generated from LSEG data August 9 at
04:57 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.70          -0.63          Beat
 Mar. 31 2024                     -0.66          
 Dec. 31 2023      -0.74          -0.75          Missed
 Sep. 30 2023      -0.59          -0.24          Beat